GÖRG, with a team led by Cologne-based partner Dr Thomas Lange, advised healthcare specialist SHS Capital on the financing of its acquisition of Ackermann Instrumente GmbH. The transaction was completed in August 2025. 

Founded in 1993 and based in Tübingen, the private equity firm SHS Capital invests in innovative European companies in the healthcare sector, focusing on expansion financing, shareholder changes, and succession situations. The national and international investors in the SHS funds include pension funds, funds of funds, entrepreneurs, and the SHS management team.

Ackermann Instrumente GmbH is a leading manufacturer of high-quality surgical instruments with a global customer base and a focus on endoscopy, implantology, and general surgery.

As part of the acquisition, the succession in the family business was reorganized: Rolf Ackermann remains as a minority shareholder and Peter Grassl continues to run the company as managing director.

SHS Capital plans to expand Ackermann's core business, for example through targeted partnerships with regional companies, and to establish a leading medtech group.

The investment was made from the sixth fund generation (SHS VI), which was launched in 2022. The fund currently has a volume of around €270 million.

The GÖRG-team provided SHS Capital with comprehensive legal advice on all financing matters.

Advisors SHS Capital

GÖRG Partnerschaft von Rechtsanwälten mbB
Dr Thomas Lange (Lead, Partner, Financing, Cologne)
Nele Motzek (Senior Associate, Financing, Cologne)
Julia Restani, LL.M. (Senior Associate, Financing, Frankfurt am Main)
Jannik Gesekus (Associate, Financing, Cologne)